logo
Select company
Select metric
Ticker Information

Ticker

GUTS

Company Name

FRACTYL HEALTH INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

FRACTYL HEALTH INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GUTS - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ -18.21M$ -99.77M0%
3/31/2025$ 6.38M$ -89.11M-1397.76%
12/31/2024$ 28.42M$ -70.43M-247.79%
9/30/2024$ 50.32M$ -68.97M-137.06%
6/30/2024$ 70.75M$ 00%
3/31/2024$ 84.18M$ 00%
12/31/2023$ -325.06M$ -94.27M0%
9/30/2023$ -307.18M$ 00%
12/31/2022$ -252.32M$ -63.63M0%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FRACTYL HEALTH INC's latest trailing twelve months (TTM) ROE stands at 0%.
  • Over the past 5 years, FRACTYL HEALTH INC's average ROE has been -594.2%.
  • The median ROE for FRACTYL HEALTH INC during this period was -247.79%
  • FRACTYL HEALTH INC reached its highest ROE over the past 5 years at -137.06%.
  • The lowest ROE recorded by FRACTYL HEALTH INC in the same timeframe -1397.76%

FRACTYL HEALTH INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
VTVT : VTV THERAPEUTICS INC -708%CDIO : CARDIO DIAGNOSTICS HOLDINGS INC -64.27%CGTX : COGNITION THERAPEUTICS INC -469.38%MAIA : MAIA BIOTECHNOLOGY INC -417.16%BGMS : BIO GREEN MED SOLUTION INC -177.03%TELO : TELOMIR PHARMACEUTICALS INC -3353.71%JSPR : JASPER THERAPEUTICS INC -386.89%KLTO : KLOTHO NEUROSCIENCES INC -106.6%ATNM : ACTINIUM PHARMACEUTICALS INC -215.83%LTRN : LANTERN PHARMA INC -153.71%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for FRACTYL HEALTH INC is calculated as follows: Net Inc. Cmn. [ $ -63.63M ] / Equity [ $ -252.32M ]
(=) ROE [ 0% ]

GUTS - Return on Equity, Last 5 years

-1397.76%

Minimum

Mar 31, 2025

-137.06%

Maximum

Sep 30, 2024

-594.2%

Average

-247.79%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.13K
min-66.24%
max73.25%
average1.63%
median6.53%
std22.52%